Corporate Presentation Date Title 2024-07-08 Corporate Presentation Presentations Date Title 2023-10-22 PRESENTATION - ESMO 2023 - Utilizing H&E Images and Digital Pathology to Predict Response to Buparlisib in SCCHN 2023-05-31 PRESENTATION - ASCO 2023 - Combination of Immune and Genetic Biomarkers of Improved Efficacy to Buparlisib and Paclitaxel in Patients with SCCHN: BERIL-1 Sub-analysis 2019-09-29 PRESENTATION - ESMO 2019 - A Phase 1b Study of E7046 (AN0025) in Combination With Radiotherapy Chemoradiotherapy (RTCRT) in Preoperative Treatment of Rectal Cancer Upcoming Events There are no upcoming events scheduled at this time. Past Events 2022-09-29 Cantor Fitzgerald's Oncology, Hematology & HemeOnc Conference